Geron

3 followers


Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Industries

Headquarters

Stage

Employees

Links

Org chart

John A. Scarlett
Chairman, President & CEO

John A. Scarlett

Collapse
Edward Koval
EVP & Chief Business Officer
Michelle Robertson
Executive Vice President, CFO & Treasurer
Anil Kapur
EVP, Corporate Strategy & Chief Commercial Officer
Melissa A. Kelly Behrs
EVP, Business Operations & Chief Alliance Officer
Faye Feller
EVP, Chief Medical Officer
Scott A. Samuels
EVP, CLO & Corporate Secretary